Effect of early salvage radiotherapy at PSA < 0.5 ng/ml and impact of post-SRT PSA nadir in post-prostatectomy recurrent prostate cancer

被引:0
|
作者
Dirk Bottke
Detlef Bartkowiak
Alessandra Siegmann
Reinhard Thamm
Dirk Böhmer
Volker Budach
Thomas Wiegel
机构
[1] Fachbereich Strahlentherapie,MVZ Klinikum Esslingen GmbH
[2] University Hospital Ulm,Department of Radiation Oncology and Radiotherapy
[3] Charité Universitätsmedizin Berlin Campus Benjamin Franklin,Department of Radiation Oncology and Radiotherapy
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:344 / 349
页数:5
相关论文
共 50 条
  • [21] PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml
    Solomonidou, Nantia
    Germanou, Daphnie
    Strouthos, Iosif
    Karagiannis, Efstratios
    Farolfi, Andrea
    Koerber, Stefan A. A.
    Debus, Juergen
    Peeken, Jan C. C.
    Vogel, Marco E. E.
    Vrachimis, Alexis
    Spohn, Simon K. B.
    Shelan, Mohamed
    Aebersold, Daniel
    Grosu, Anca-Ligia
    Ceci, Francesco
    Kroeze, Stephanie G. C.
    Guckenberger, Matthias
    Fanti, Stefano
    Belka, Claus
    Hruby, George
    Scharl, S.
    Wiegel, Thomas
    Bartenstein, Peter
    Henkenberens, Christoph
    Emmett, Louise
    Schmidt-Hegemann, Nina Sophie
    Ferentinos, Konstantinos
    Zamboglou, Constantinos
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (08) : 2529 - 2536
  • [22] DETECTION OF CIRCULATING TUMOUR CELLS IN PROSTATE CANCER PATIENTS WITH RISING PSA POST-PROSTATECTOMY
    Sexton, T.
    Allan, A.
    Hedley, B.
    Rodrigues, G.
    Venkatesan, V.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S16 - S16
  • [23] PSA Nadir of &lt;0.5 ng/mL following Brachytherapy for Early Stage Prostate Adenocarcinoma Predicts for Freedom From PSA Failure and Distant Metastasis
    Ko, E. C.
    Stone, N. N.
    Stock, R. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S148 - S149
  • [24] Preliminary results of three dimensional conformal radiotherapy as salvage treatment for post-prostatectomy patients with rising PSA.
    Wood, CG
    Rosen, LR
    Woo, T
    Shepherd, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 440S - 440S
  • [25] Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience
    Jure Murgic
    Blanka Jaksic
    Marin Prpic
    Davor Kust
    Amit Bahl
    Mirjana Budanec
    Angela Prgomet Secan
    Pierfrancesco Franco
    Ivan Kruljac
    Borislav Spajic
    Nenad Babic
    Bozo Kruslin
    Mario Zovak
    Eduardo Zubizarreta
    Eduardo Rosenblatt
    Ana Fröbe
    Radiation Oncology, 16
  • [26] Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience
    Murgic, Jure
    Jaksic, Blanka
    Prpic, Marin
    Kust, Davor
    Bahl, Amit
    Budanec, Mirjana
    Prgomet Secan, Angela
    Franco, Pierfrancesco
    Kruljac, Ivan
    Spajic, Borislav
    Babic, Nenad
    Kruslin, Bozo
    Zovak, Mario
    Zubizarreta, Eduardo
    Rosenblatt, Eduardo
    Frobe, Ana
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [27] Achieving "Zero PSA" Following Post-Prostatectomy Radiation Therapy for Lymph Node Positive Prostate Cancer in the Ultrasensitive PSA Era
    Tom, M. C.
    Mian, O. Y.
    Stephans, K. L.
    Reddy, C. A.
    Xu, S. H.
    Rini, B.
    Garcia, J. A.
    Ornstein, M. C.
    Klein, E. A.
    Stephenson, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E145 - E145
  • [28] Upfront Androgen Deprivation Therapy With Salvage Radiation May Improve Biochemical Outcomes in Prostate Cancer Patients With Post-Prostatectomy Rising PSA
    Jang, Joanne W.
    Hwang, Wei-Ting
    Guzzo, Thomas J.
    Wein, Alan J.
    Haas, Naomi B.
    Both, Stefan
    Vapiwala, Neha
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (05): : 1493 - 1499
  • [29] Impact and efficacy of 68GA-PSMA PET/CT in recurrent prostate cancer patients with PSA &lt;0.5 ng/ml
    Siepe, G.
    Buwenge, M.
    Capocaccia, I.
    Farolfi, A.
    Graziani, T.
    Castellucci, P.
    Ntreta, M.
    Macchia, G.
    Deodato, F.
    Cilla, S.
    Cammelli, S.
    Frezza, G. P.
    Fanti, S.
    Morganti, A. G.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S329 - S330
  • [30] [18F]DCFPyL PET/CT in detection and localization of recurrent prostate cancer following prostatectomy including low PSA < 0.5 ng/mL
    Elisa Perry
    Arpit Talwar
    Kim Taubman
    Michael Ng
    Lih-Ming Wong
    Russell Booth
    Tom R. Sutherland
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2038 - 2046